Your browser doesn't support javascript.
loading
A comprehensive strategy for quality evaluation of Wushe Zhiyang Pills by integrating UPLC-DAD fingerprint and multi-ingredients rapid quantitation with UPLC-MS/MS technology.
Jiang, Maoyuan; Cao, Jiliang; Zhang, Chunbo; Su, Biru; Wang, Shengpeng; Ning, Na; Lei, Ting; Li, Peng.
Affiliation
  • Jiang M; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
  • Cao J; College of Pharmacy, Shenzhen Technology University, Shenzhen, China.
  • Zhang C; Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, Guangzhou, China.
  • Su B; Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, Guangzhou, China.
  • Wang S; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China. Electronic address: swang@um.edu.mo.
  • Ning N; Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, Guangzhou, China.
  • Lei T; Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, Guangzhou, China.
  • Li P; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China. Electronic address: pli1978@hotmail.com.
J Pharm Biomed Anal ; 210: 114556, 2022 Feb 20.
Article in En | MEDLINE | ID: mdl-34979493

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Chinese Herbal / Tandem Mass Spectrometry Type of study: Prognostic_studies Language: En Journal: J Pharm Biomed Anal Year: 2022 Document type: Article Affiliation country: China Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Chinese Herbal / Tandem Mass Spectrometry Type of study: Prognostic_studies Language: En Journal: J Pharm Biomed Anal Year: 2022 Document type: Article Affiliation country: China Country of publication: United kingdom